The importance of CGRP extends beyond its use as a possible therapeutic target, as it has also been proposed as a biomarker for migraine and for its therapeutical response [32,33,34], particularly α-CGRP due to its predominance in both the central and peripheral nervous system, as mentioned before. This evidence concerns the gene CALCA and migraine disorder.